Reported 1 day ago
Sana Biotechnology Inc. (NASDAQ:SANA) is enhancing its management team following the retirement of Executive Vice President Bernard J. Cassidy, effective October 20, 2025, for personal reasons. Aaron M. Grossman will take over as the new executive vice president and chief legal officer, as the company focuses on advancing treatments for type 1 diabetes and other immune diseases through its innovative Hypoimmune (HIP) platform.
Source: YAHOO